Title: Zhou W , et al. A practical approach to asymmetric synthesis of dolastatin 10. Org Biomol Chem. 2017;15(29):6119-6131.
130199-65-4
144774-97-0
1430213-30-1 | ML216 | AA009CAO | MFCD24849400
1423186-80-4 | RIP2 kinase inhibitor 1 | AA009CKX | MFCD30489727
13656-52-5 | 4,5-Dichloro-2-fluorobenzenesulphonyl chloride | AA009D32 | MFCD03094453
1344046-12-3 | 3-Bromoquinoline-5-carboxylic acid | AA009DCC | MFCD20327981
1256643-38-5 | 9-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxylic acid | AA009DR7 | MFCD00133512
1256643-58-9 | 3-Methyl-3H-[1,2,3]triazolo[4,5-b]pyridine-6-carboxylic acid | AA009DUD | MFCD18381892
135308-74-6 | D,L N,O-Didesmethylvenlafaxine | AA009E0C | MFCD04039515
131944-48-4 | (E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity | AA009E70 | MFCD28988714
1221-70-1 | DesMethyl DoxylaMine | AA009EGG | MFCD31562535
1290041-88-1 | Des-N-Ethyl 3,5-DiMethylacetildenafil | AA009EOF